SOURCES SOUGHT
66 -- ARS-M840 AUTOMATED SAMPLING SYSTEM - ARS-M840 AND COMPONENTS
- Notice Date
- 6/10/2011
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, Bldg 50 Room 422, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- 1088708
- Archive Date
- 7/2/2011
- Point of Contact
- Thomas M Dumas, Phone: 404-253-1253
- E-Mail Address
-
thomas.dumas@fda.hhs.gov
(thomas.dumas@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- ARS-M840 AND COMPONENTS THIS IS FOR MARKET RESEARCH PURPOSES ONLY, NOT A REQUEST FOR QUOTE OR SOLICITATION. The Food and Drug Administration is seeking business sources, including 8(a) certified businesses, service-disabled veteran owned small businesses, HUB Zone small businesses, small disadvantaged business, veteran-owned small business, and women-owned small businesses to purchase as Brand Name or Equal to an ARS M840 Automated Sampling System with Interface to Agilent HPLC System to include the following: (SEE ATTACHMENT) PART 1 - DESCRIPTION/SPECIFICATIONS/WORK STATEMENT 1. BACKGROUND AND OBJECTIVES This equipment will be used for the collection and preparation of protein products from cell culture lines in a parallel bioreactor system. The system must perform all functions of sample acquisition, transfer, assay and/or sample storage without contamination of the bioreactor. 1.1 Salient Characteristics of the laboratory equipment: 1.1.1 A parallel system capable of sampling from at least 8 bioreactors system with the ability to extract cell containing samples for analyzers that utilize them (i.e. cell counter, nutrient analyzer) and able to remove cells for analyzers that need to be cell free (i.e. HPLC) 1.1.2 Utilize a sanitary sampling interface, located near the bioreactors to clean the sample transfer lines and the valves in the module and provides complete isolation of the reactor from the system to allow cleaning and flushing directly to the reactor port to protect the reactor from contamination. Multiple isolation valves should be in series with at least one drain valve and must be controlled automatically by the system. Capable of delivering the samples to at least 4 separate analytical or storage instruments. 1.1.3 Capable of performing dilutions prior to delivery to external analytical instruments such as cell counters or adding selected buffer to samples prior to HPLC analysis. 1.1.4 Flexibility in the analytical output to allow online analysis by a number of different analytical methods such as High Performance liquid chromatography, nutrient monitoring devices, cell counters and sample collection/storage apparatus. 1.1.5 Capable of physical and software integration of optional 3rd party software and accessories such as a Dasgip Bioreactor through OPC control to allow automated sampling and the creation of a feedback loop to incorporated into system's controls. 1.1.6 Clean in place capabilities to prevent microbial contamination using 0.22 micron filtered prepackaged reagents for quick and aseptic installation. 1.1.7 Provide a physical and OPC software interface for a NOVA nutrient analyzer to allow sample delivery and OPC feedback of the values 1.1.8 Provide a physical and OPC software interface for an Agilent High performance liquid chromatography (HPLC) system with in line filtration of cells prior to sample delivery and OPC feedback of the values. 1.1.9 Provide an aseptic sample collection device capable of maintaining at least 60 samples at 4degress C. Each response should include the following Business Information: a. DUNS b. Company Name c. Company Address d. Current GSA Schedules appropriate to this Sources Sought. e. Do you have a Government approved accounting system? If so, please identify the agency that approved the system. f. Type of Company (i.e. small business, 8(a), woman owned, veteran owned, etc.) as validated via the Central Contractor Registration (CCR). All offerors must register on the CCR located at http://www.ccr.gov/index.asp g. Company Point of Contact, Phone and Email Address GENERAL INFORMATION This Sources Sought Notice is for information and planning purposes only and should not be construed as a commitment by the Government. This is not a solicitation announcement for proposals and no contract will be awarded from this Notice. No reimbursement will be made for any costs associated with providing information in response to this Notice. Respondents will not be notified of the results of this evaluation. The Government will not entertain questions regarding this Market Research. Interested Contractors are requested to provide information, brochures, literature, published price list, etc. Information can be submitted by mail or email to the Contract Specialist at the Food and Drug Administration, ATTN: Thomas Dumas, 60 8th St., NE, Atlanta, GA 30309 or thomas.dumas@fda.hhs.gov not later than 12:00 p.m. EST 17 June 2011.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/1088708/listing.html)
- Place of Performance
- Address: Food and Drug Administraton, 10903 New Hampshire Ave, WO Building 62, Silver Spring, Maryland, 20903, United States
- Zip Code: 20903
- Zip Code: 20903
- Record
- SN02469552-W 20110612/110610234851-37d81aecbcca610cbe48fd81bb07c44c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |